Shanin Specter is a lawyer and the son of former Senator and Chairman of the Senate Judiciary Committee Arlen Specter.
The following are the words spoken by a federal judge regarding the ethics of Mr. Specter and his law partner, Tom Kline, as they promoted their two websites which all those harmed in an enormous class action pharmaceutical law suit should register. You’ve got to see what a judge had to say.
“Judge Stearns” is U.S. District Judge Richard G. Stearns of the District of Massachusetts
In the May decision, Stearns noted that some of the lawyers who were handling state court Lupron cases, including those in California, Texas and Illinois, had agreed early on to “coordinate discovery efforts” with the lead lawyers appointed in the federal MDL case.
But Kline & Specter “refused to join in the cooperative effort,” Stearns wrote, and “instead embarked on a pre-emptive strategy to seize control of the litigation by using the state court proceedings to gain leverage over counsel cooperating with the MDL action.”
Kline represented Victim 5 in the case and said this was all about justice.
Stearns faulted Kline & Specter for launching a pair of Internet Web sites that, Stearns said, were “intended to mislead potential members of the [federal multi-district litigation] MDL class.”
He also faulted Kline & Specter for sending a “Dear Client” letter to “every person who had registered” on the firm’s Web sites. The letter, according to Stearns, contained “a number of deliberate misrepresentations and falsehoods.”
“…Web sites established by Kline & Specter under the domain names http://www.lupronlaw.com and http://www.lupronclass.com that offered to “welcome” potential members to “the class” and invited purchasers of the drug “to register for the Lupron class action.”
After reviewing the Web sites, Stearns issued an order in which he found that the sites were intended to mislead potential members of the MDL class.
Get this:
Stearns said he concluded “the typical registrant on a Kline & Specter Web site would not know that he or she was opting out as a participant in the MDL class by ¿registering’ with Kline & Specter. Moreover, neither of the Web sites explained that a registrant who opted for inclusion ¿in litigation in the state courts’ might (depending on his or her state of residence) be left with no means of recovery.”
The ruling said that while Kline & Specter was “perfectly free to criticize the proposed settlement agreement … they are not privileged to engage in deceptive conduct manipulating the very consumers they claim to protect.”